Here are five things to know.
1. The product was distributed to wholesalers and hospitals around the country from May 15 through Aug. 14.
2. AuroMedics has notified customers of the recall via recall letters.
3. Use of the product should be immediately discontinued and could potentially result in fatal infections in many patients.
4. AuroMedics has not received any reports of adverse events attributable to the recalled antibiotic.
5. Linezolid injection is used to treat multiple infections caused by gram-negative bacteria, including vancomycin-resistant Enterococcus faecium, community-acquired pneumonia and diabetic foot infections.
More articles on supply chain:
Mallinckrodt to acquire Sucampo Pharmaceuticals for $1.2B: 3 things to know
Teen inspires Dignity Health CEO to cut plastic straw use across system’s 39 hospitals
5 latest FDA approvals
